WO2008094507A3 - Novel fusion compounds - Google Patents
Novel fusion compounds Download PDFInfo
- Publication number
- WO2008094507A3 WO2008094507A3 PCT/US2008/001092 US2008001092W WO2008094507A3 WO 2008094507 A3 WO2008094507 A3 WO 2008094507A3 US 2008001092 W US2008001092 W US 2008001092W WO 2008094507 A3 WO2008094507 A3 WO 2008094507A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel fusion
- fusion compounds
- compounds
- compositions
- management
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/46—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with acyclic hydrocarbon radicals or such radicals substituted by carbocyclic or heterocyclic rings, attached to the carboxamido radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to novel compounds derived from compounds having antibiotic activities. The invention further provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by anti-infective agents, particularly those relating to the management of bacterial infection.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89798107P | 2007-01-26 | 2007-01-26 | |
US60/897,981 | 2007-01-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008094507A2 WO2008094507A2 (en) | 2008-08-07 |
WO2008094507A3 true WO2008094507A3 (en) | 2008-10-02 |
Family
ID=39674685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/001092 WO2008094507A2 (en) | 2007-01-26 | 2008-01-25 | Novel fusion compounds |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008094507A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9393250B2 (en) | 2012-04-12 | 2016-07-19 | University Of Saskatchewan | Phthalocyanine compounds useful as RecA inhibitors and methods of using same |
MX2015011948A (en) | 2013-03-08 | 2015-12-09 | Allergan Inc | Antibiotic conjugates directly linked with steroid drugs. |
SG11201507241UA (en) | 2013-03-08 | 2015-10-29 | Allergan Inc | Cyclosporine a-steroid conjugates |
MA44037B1 (en) | 2016-06-06 | 2020-03-31 | Arena Pharm Inc | Beta 3 adrenergic receptor modulators useful in the treatment or prevention of disorders associated therewith |
CN106565654B (en) * | 2016-10-14 | 2018-08-31 | 云南中烟工业有限责任公司 | A kind of novel flavone compound, Its Preparation Method And Use extracted from Bai Yun Shen |
CR20220316A (en) | 2019-12-06 | 2022-10-07 | Vertex Pharma | Substituted tetrahydrofurans as modulators of sodium channels |
AU2021244718A1 (en) * | 2020-03-23 | 2022-11-03 | John M.H. GREGG | Anti-viral compounds and methods for administration thereof |
CN117794920A (en) | 2021-06-04 | 2024-03-29 | 沃泰克斯药物股份有限公司 | N- (hydroxyalkyl (hetero) aryl) tetrahydrofurancarboxamides as sodium channel modulators |
CN114315812A (en) * | 2021-12-31 | 2022-04-12 | 广西师范大学 | Two alkaloid compounds derived from marine fungi, and their preparation methods and application in preparing antiinflammatory medicine |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050119269A1 (en) * | 2003-10-28 | 2005-06-02 | Rao Yeleswarapu K. | Heterocyclic compounds and methods of making and using thereof |
-
2008
- 2008-01-25 WO PCT/US2008/001092 patent/WO2008094507A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050119269A1 (en) * | 2003-10-28 | 2005-06-02 | Rao Yeleswarapu K. | Heterocyclic compounds and methods of making and using thereof |
Non-Patent Citations (1)
Title |
---|
DA SILVA ET AL.: "Biological Activity and Synthetic Metodologies for the Preparation of Fluoroquinolones, A Class of Potent Antibacterial Agents", CURRENT MEDICINAL CHEMISTRY, vol. 10, 2003, pages 21 - 39 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008094507A2 (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008094507A3 (en) | Novel fusion compounds | |
WO2007130655A3 (en) | Phage derived antimicrobial activities | |
TW200716519A (en) | Benzoyl-substituted serineamides | |
WO2007120980A3 (en) | 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases | |
WO2008051416A3 (en) | Compounds that inhibit the activity of hsp90 for treating infections | |
WO2010063996A3 (en) | Antibacterial compounds | |
WO2008115281A3 (en) | Compounds for treating viral infections | |
WO2010090860A3 (en) | Methods and compositions for treating bacterial infection | |
UA95644C2 (en) | Pyridizinone derivative, pharmaceutical composition and treatment method | |
TW200716558A (en) | Heteroaroyl-substituted serineamides | |
WO2008073933A3 (en) | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use | |
WO2007092622A3 (en) | Compositions and methods for treating bone | |
IN2012DN00785A (en) | ||
TW200734344A (en) | Antibacterial agents | |
WO2007067559A3 (en) | Antibacterial agents | |
WO2009026166A3 (en) | Antiinfective flavonol compounds and methods of use thereof | |
WO2007085852A3 (en) | Antimicrobial materials | |
WO2006120563A3 (en) | Antibacterial agents | |
EP2331093A4 (en) | Compounds, compositions and methods for reducing toxicity and treating or preventing diseases | |
WO2007109105A3 (en) | Flavivirus inhibition by sultams and related compounds | |
WO2010151784A3 (en) | Antimicrobial compounds | |
WO2008133734A3 (en) | Method and compositions for treating hiv infections | |
WO2007097981A3 (en) | Alpha carbolines and uses thereof | |
WO2010075280A3 (en) | Coumarin-based compounds for the treatment of alzheimer's disease and cancer | |
WO2010032011A8 (en) | Anti-fungal therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08724872 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08724872 Country of ref document: EP Kind code of ref document: A2 |